Meningococcal disease and its control with meningococcal polysaccharide vaccines

This article summarizes background information and specific evidence regarding the use of meningococcal polysaccharide vaccines. On the basis of currently available data, it seems premature to recommend that immunization against meningococcal disease be included within routine immunization programme...

Full description

Saved in:
Bibliographic Details
Published in:Bulletin of the World Health Organization 1982, Vol.60 (1), p.1-7
Main Author: Galazka, A
Format: Article
Language:English
Subjects:
Adolescent
Adult
Bacterial Vaccines - standards
Child
Child, Preschool
Female
Humans
Immunity, Maternally-Acquired
Infant
Infant, Newborn
Meningococcal Infections - immunology
Meningococcal Infections - prevention & control
Polysaccharides, Bacterial - therapeutic use
Pregnancy
Quality Control
Update
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This article summarizes background information and specific evidence regarding the use of meningococcal polysaccharide vaccines. On the basis of currently available data, it seems premature to recommend that immunization against meningococcal disease be included within routine immunization programmes in developing countries. Factors contributing to this judgement include the irregularity of epidemics, the changing serogroups of meningococci, the different age distribution of cases in different areas, low efficacy of a single dose of meningococcal vaccine in children below 2 years of age, short duration of post-immunization immunity in infants and young children, and finally, the still high cost of current meningococcal vaccines.The meningococcal vaccines can be effective, however, in controlling epidemics due to meningococci of serogroups A or C provided they are quickly administered to the age groups within the population who are most at risk.
ISSN:0042-9686